New 12-Month Preclinical Milestone in Regenerative Aesthetics
Conexeu completed a 12-month multi-tissue preclinical program in aesthetics. The program met its pre-defined objectives.
Conexeu is developing CXU™, an injectable bioregenerative extracellular matrix platform designed to support the restoration of soft tissue structure, function and form.
Many established aesthetic injectables primarily reduce muscle activity, add volume or stimulate collagenproduction; CXU is being developed around a different scaffold-based hypothesis.
The opportunity is not only to restore form, but to explore whether structural scaffolding can support the biology associated with tissue remodeling.
At room temperature, CXU flows as a liquid, allowing for placement into the tissue with a fine-gauge needle.
Its flow characteristics are designed to support controlled injectable placement within the treatment area.
At body temperature, CXU transitions into a gel, allowing for stability that may provide immediate volume.
Over time, CXU may provide structural support as tissue integration, remodeling and regeneration occur.
Bioregeneration is an emerging area of aesthetic science focused on supporting the body’s ability to restore tissue structure and function over time.
While many traditional aesthetic treatments focus on muscle activity, volume or collagen stimulation, bioregenerative approaches explore the biology of repair and remodeling.
For Conexeu, this means designing materials that may help create the right environment for new tissue development, while gradually resorbing as the body remodels.
As the field of aesthetics continues to evolve, patients and providers are increasingly looking for outcomes that appear natural, integrate with the body and support long-term tissue quality.
Bioregeneration may represent an important next step in that evolution. The goal is not simply to fill space, but to support tissue restoration.
How CXU Works
CXU is designed as a flowable collagen-ECM scaffold intended to conform to soft-tissue spaces and support host-tissue interaction and remodeling.9,3,6
Designed to:
Designed to:
Designed to:
When tissue quality changes due to age, environmental exposure, or significant weight loss, CXU™ is designed to help create the conditions for soft tissue restoration.*
Designed to provide structural and volumizing support at the time of placement. 1,5,7,9,12
Designed to support cellular ingrowth and remodeling.3,9,10,12
Designed to resorb over time in support of host tissue remodeling.12
Being developed as an injectable, non-surgical approach to soft-tissue augmentation.1,5,9,10,12
Designed to be biocompatible and to minimize inflammatory response.10,12
Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage, and going through the cites of the word in classical literature, discovered the undoubtable source.Lorem Ipsum comes from sections 1.10.32 and 1.10.33 of "de Finibus Bonorum et Malorum" (The Extremes of Good and Evil) by Cicero, written in 45 BC. This book is a treatise on the theory of ethics, very popular during the Renaissance. The first line of Lorem Ipsum, "Lorem ipsum dolor sit amet..", comes from a line in section 1.10.32.The standard chunk of Lorem Ipsum used since the 1500s is reproduced below for those interested. Sections 1.10.32 and 1.10.33 from "de Finibus Bonorum et Malorum" by Cicero are also reproduced in their exact original form, accompanied by English versions from the 1914 translation by H. Rackham.